Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Neoplasms

1,4-phenylenebis(methylene)selenocyanate has been researched along with Neoplasms in 2 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimada, T1
Murayama, N1
Tanaka, K1
Takenaka, S1
Guengerich, FP1
Yamazaki, H1
Komori, M1

Other Studies

2 other studies available for 1,4-phenylenebis(methylene)selenocyanate and Neoplasms

ArticleYear
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Chemical research in toxicology, 2011, Aug-15, Volume: 24, Issue:8

    Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalyti

2011
Clinical development plan: 1,4-penylenebis(methylene)selenocyanate.
    Journal of cellular biochemistry. Supplement, 1996, Volume: 26

    Topics: Animals; Anticarcinogenic Agents; Clinical Trials, Phase I as Topic; Dogs; Drug Approval; Female; Hu

1996